Teva's asthma treatment fails late-stage studies
January 22, 2018 at 08:23 AM EST
Jan 22 (Reuters) - Teva Pharmaceutical Industries said on Monday two late-stage studies testing its treatment for asthma did not meet their main goals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|